Furosemide Injection, Solution
Product Images NDC 55154-4452

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 55154-4452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-image-01-structure.jpg (Spl Image 01 Structure)

Spl-image-01-structure.jpg (Spl Image 01 Structure)
Chemical structure of furosemide, showing its molecular components including a benzene ring, carboxyl group, sulfonamide group, chlorine atom, and a furan ring. The image also displays the molecular formula C12H11ClN2O5S and molecular weight 330.74.*
FDA Label Image

40mg/4ml Bag Label (B4c1ae97 0f6c 4ae1 858a 4e0ab8f1ce53 00)

40mg/4ml Bag Label (B4c1ae97 0f6c 4ae1 858a 4e0ab8f1ce53 00)
Label for FUROSEMIDE Injection, USP 40 mg/4 mL (10 mg/mL) in a package of 5 single-dose 4 mL vials. It is for intravenous or intramuscular use, specifying storage instructions and warnings. The label lists ingredients including furosemide and sodium chloride, and notes the manufacturer as Baxter Healthcare Corporation, with distribution by Cardinal Health 107, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.